New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.

FDA Approves Medtronic's Symplicity Spyral for Hypertension

The device uses radiofrequency energy to denervate renal arteries, offering a transformative solution for significant blood pressure reduction.

Medtronic
Medtronic

A recent Medscape article noted the FDA’s approval of Medtronic's Symplicity Spyral renal denervation system to treat hypertension. The catheter-based approach uses radiofrequency energy to denervate the renal arteries. The FDA's Circulatory System Devices Panel previously deemed the system safe in August, though opinions were divided on its efficacy and risk-benefit profile. 

As part of the Medtronic SPYRAL HTN Global Clinical Program, over 25,000 patients worldwide were treated, showing a significant reduction in ambulatory systolic blood pressure. The approval is seen as an important step toward treating hypertension, in addition to medication and lifestyle changes. 

Discover the right packaging solutions for life sciences in Philadelphia
Explore innovative packaging and supply chain solutions for the life sciences at the largest PACK EXPO East in history, March 18–20. Get ideas from 400+ top exhibitors and connect with colleagues and industry experts—all in one convenient location!
Read More
Discover the right packaging solutions for life sciences in Philadelphia
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub